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Summary objective To determine the clinical profile and outcomes of health care workers (HCWs) with
extensively drug resistant tuberculosis (XDR-TB) in the Eastern and Western Cape Provinces of South
Africa.
method Retrospective case record review of 334 patients with XDR-TB reported during the period
1996–2008 from Western and Eastern Cape Province, Cape Town, South Africa. Case records of HCWs
with XDR-TB were analysed for clinical and microbiological features, and treatment outcomes.
results From 334 case records of patients with XDR-TB, 10 HCWs were identified. Eight of ten were
HIV-uninfected, and four of 10 had died of XDR-TB despite treatment. All 10 HCWs had received an
average of 2.4 courses of TB treatment before being diagnosed as XDR-TB.
conclusions In the Eastern and Western Cape provinces of South Africa XDR-TB affects HCWs, is
diagnosed rather late, does not appear to be related to HIV status and carries a high mortality. There is
an urgent need for the South African government to implement WHO infection control recommenda-
tions and make available rapid drug susceptibility testing for HCWs with suspected multidrug-resistant
(MDR) ⁄XDR-TB. Further studies to establish the actual risk and sources of infection (nosocomial or
community) are required.
keywords extensively drug-resistant, tuberculosis, health worker
Introduction
Multidrug (MDR)- and extensively drug (XDR)-resistant
tuberculosis (TB) carry a high mortality rate and are a
growing problem that threatens to destabilize tuberculosis
control globally (WHO Report. World Health Organiza-
tion, 2010; WHO, 2010; Centers for Disease Control and
Prevention, 2006; Sotgiu et al. 2009; Gandhi et al. 2006).
South Africa has a very high annual TB incidence of 948
per 100 000 population ⁄ year with approximately 8000–
9000 patients per annum with multidrug-resistant TB
(MDR-TB) passively detected per annum. The most recent
report of 5% of the patients with MDR-TB being exten-
sively drug-resistant TB (XDR-TB) in South Africa is likely
an underestimate (WHO Report. World Health Organi-
zation, 2010; WHO, 2010). TB in all its forms is having a
devastating effect on the world’s population and poses a
great risk to the health and work outputs of health care
workers (HCWs) (Menzies et al. 2007; Naidoo & Jinabhai
2006; Jo et al. 2008; Pillay & Malhati 2008; Galgalo et al.
2008; Joshi et al. 2006).
Health care workers in South Africa are at the forefront
of the battle against the TB and HIV ⁄AIDS epidemics
(Naidoo & Jinabhai 2006; Joshi et al. 2006; Shisana et al.
2004). The shortage of HCWs has reached alarming levels
in sub-Saharan Africa, which is home to 11% of the
world’s population and 24% of the global burden of
disease, but only 3% of the world’s HCWs (Wilkinson &
Gilks 1998). Multiple factors contribute to this problem,
such as high workload, poor remuneration, limited training
opportunities and lack of resources (Pillay & Malhati
2008). Other significant contributing factors are fatalities
and incapacitating disability related to HIV ⁄AIDS and
other infectious diseases of poverty. In 2002, an estimated
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16% of HCWs in South Africa were infected with HIV
(Shisana et al. 2004). South Africa has one of the highest
rates of TB and HIV ⁄AIDS in the world, and the
occurrence of TB in HCWs has been reported to be
substantial (Naidoo & Jinabhai 2006; Shisana et al. 2004;
Wilkinson & Gilks 1998). However, the occurrence and
importance of XDR-TB in HCWs in South Africa are not
yet documented.
Health care workers with active tuberculosis (TB) need
to be identified and treated. HCWs with active TB risk
infecting their patients, their fellow staff, families and
communities with Mycobacterium tuberculosis (Mtb).
Conversely, HCWs are also at risk of acquiring TB from
their patients, fellow staff and family and community
members. Over the past 15 years, the risk of TB in HCWs
in southern Africa has been increased because of the
resurgence of TB caused by the HIV epidemic and the
emergence of MDR- ⁄XDR-TB, which has added significant
strain to already overwhelmed TB control programmes
(Gandhi et al. 2006; Naidoo & Jinabhai 2006; Shisana
et al. 2004). The prevalence of extensively drug-resistant
tuberculosis (XDR-TB) is now being increasingly
reported from South Africa (Gandhi et al. 2006; Dheda
et al. 2010) and poses a major threat to HCWs and other
patients in the wards and outpatient clinics, and those in
congregate settings. XDR-TB is difficult to treat and has
poor treatment outcomes, and together with HIV co-
infection, may exacerbate the shortage and poor perfor-
mance of HCWs in South Africa. The frequency, clinical
profile and outcomes of HCWs with XDR-TB in South
Africa remain unknown (Sotgiu et al. 2009). To ascertain
whether XDR-TB is an emerging problem in HCWs in
South Africa, we undertook a retrospective case record
review of 334 patients with XDR-TB reported during the
period 1996–2008 from the Eastern and Western Cape
Provinces of South Africa.
Methods and patients
Using a validated data capture tool, we performed a
retrospective study of case records of 334 patients with
XDR-TB, diagnosed between January 1996 and February
2008, from the Western Cape and Eastern Cape provinces
of South Africa. For the HCWs identified with XDR-TB,
patient data, including demographics, microbiologic and
treatment records, were collected. The diagnosis of XDR-
TB was based on sputum culture positivity for Mtb bacilli,
and was defined, based on drug susceptibility testing
(DST), as resistant to isoniazid, rifampicin, any one
fluoroquinolone and at least one-second-line injectable
anti-TB drug. Case definitions for diagnosis and conversion
are outlined in Table 1.
Results
Ten HCWs with XDR-TB were identified. Table 1 outlines
patient characteristics, including gender, HIV status,
occupation, place of work, number of previous TB
episodes, chest X-ray abnormalities, number of resistant
drugs, treatment accorded and treatment outcomes.
Patients were predominantly female (9 of 10) with a
median age of 40 years (range 26–50). The majority of
patients (6 of 10) worked as nursing staff and one each in
the following professions: doctor, radiographer, laundry
staff and ward cleaner. Of the 10 patients, eight were HIV-
uninfected. One HIV-positive patient had been treated
with anti-retrovirals (ARVs) for 4 years prior to diagnosis
of XDR-TB, and the other HIV-uninfected patient was
started on ARVs at the time of XDR-TB diagnosis. All 10
patients had been treated for TB previously with an
average of 2.4 previous TB episodes. The median duration
of follow-up was 10 months (range 1–22 months) from the
time of XDR-TB diagnosis.
Table 2 shows the individual patient characteristics (age,
gender, year of diagnosis, occupation, HIV status, drug-
resistant patterns and treatment accorded and treatment
outcome) of the 10 HCWs with XDR-TB that were
studied. Three patients underwent surgical resection
because of failure to improve clinically, and they had
unilateral disease. A high mortality was observed (4 of 10
patients died). Para-amino-salicylic acid (PAS) and cap-
reomycin became available again in South African gov-
ernment-run hospitals in late 2006. Seven patients were
treated with regimens containing these drugs, two patients
were diagnosed and died before these drugs were available
and one patient responded to a modified MDR-TB regimen
which did not include capreomycin or PAS. Four patients
died and six were still being maintained on treatment for
XDR-TB at the end of the study.
Discussion
This case series study adequately answers our primary
study aim, confirming that XDR-TB in HCWs is an
important clinical problem, and should be of major
concern to TB programme managers in South Africa. It
affects a spectrum of HCWs, particularly nurses in the
Western and Eastern Cape Provinces of South Africa.
Whilst in MDR-TB sputum culture conversion is usually
achieved in most patients within 3–4 months (WHO,
2010) of initiation of MDR-TB therapy, six of the 10
HCWs with XDR-TB in this study did not achieve culture
conversion within this time frame. Moreover, two of the
four converters reverted back to culture positivity prior to
the end of follow-up, and the overall mortality was high
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(40%). Thus, treatment-related outcomes seen in this
limited case series of 10 patients were poor. This is
concordant with other observations on treatment success
(cured and completed) ranging from 34% to 67% and
mortality of 7–36% in non-HCW populations (Sotgiu
et al. 2009).
Health care workers acquiring XDR-TB adds to the
growing burden of drug-resistant disease. It also concur-
rently exacerbates the shortage of HCWs as they can no
longer work while undergoing prolonged inpatient treat-
ment and during convalescence (Pillay & Malhati 2008;
Wilkinson & Gilks 1998; Dheda et al. 2010; World Health
Organization, 2006). This emphasises the need for inten-
sified HCW screening, the widespread use of newer tools
now available for the rapid diagnosis of MDR- ⁄XDR-TB
and instituting appropriate effective treatment. Impor-
tantly, the delay in diagnosis of XDR-TB in these HCWs
indicates that undiagnosed and untreated, they are a risk to
inpatients they manage, other fellow staff, and their
families and communities.
Because of the limitations of our study design and the
data obtained, it is unclear where and from whom the
HCWs acquired the infection: in hospital as a nosocomial
infection from inpatients with XDR-TB they cared for or
from the community where XDR-TB is becoming more
prevalent. Nosocomial transmission of drug-resistant Mtb
strains has been well documented and therefore HCWs are
clearly at risk (Gandhi et al. 2006; Menzies et al. 2007).
Given that HCWs in our study were previously treated for
TB, (including on at least two previous TB episodes in eight
patients), community acquired, rather than nosocomial,
XDR-TB may be a possibility. However, given the high
prevalence of previous TB in patients with drug resistance
in the Western Cape (Dheda et al. 2010) and studies
demonstrating re-infection as an important modality of
transmission (Verver et al. 2005), it is imperative that the
transmission dynamics of these infections be ascertained.
However, without identification of the Mtb strains and
their molecular typing data from the HCWs studied, and
from the index case, and from prior TB episodes, it was not
possible to determine the transmission dynamics in the
cases that we describe. The transmission patterns of drug-
resistant Mtb strains and whether XDR-TB may harbor
different Mtb isolates and strains are unknown. Recent
observations that Mtb strains have a rapid rate of molec-
ular evolution at the hypervariable and immunogenic Mtb
PPE38 gene region, which may lead to evasion by the
immune system, may be important. It may also be thatMtb
strains may be more diverse than previously thought
(McEvoy et al. 2009). Prospective studies are now required
to address these important issues for proper interventions
to be developed.
Table 1 Summary characteristics of health care workers with
XDR-TB
N = 10 (%)
Gender
Male 1
Female 9
Median age in years (range) 41 (26–50)
Year of XDR diagnosis*
1996 1
2002 1
2006 2
2007 4
2008 2
HIV
Positive 2
Negative 8
Previous TB 10 (100%)
Mean no. of previous TB episodes 2.4
Median duration of follow-up (months) 10 (range 1–22)
Surgical resection performed 3 (30%)
Chest X-ray abnormalities
Bilateral, non-cavitary 2
Bilateral, cavitary 4
Unilateral, noncavitary 1
Unilateral, cavitary 2
Not recorded 1
Occupation
Nurse 5
Nursing student (3rd year) 1
Physician 1
Cleaner 1
Laundry staff 1
Radiographer 1
Facilities where patient worked
District hospital 3
Specialised TB hospital 1
Prison 1
Variable (nursing student) 1
Physiotherapist office 1
Not recorded 3
Mean no. of resistant drugs 5
Median Time from MDR to XDR
(months)
19 (range 0–74)
No. of pts who converted cultures
to negative
4
Median time to culture conversion
(months)§
1.7 (range 1.2–6.9)
Mean no. of drugs in treatment regimen 7
Outcomes 7
Died 4
Still on treatment 6
XDR-TB, extensively drug-resistant tuberculosis; MDR, multidrug-
resistant.
*Date of diagnosis is the date the first sputum, culture positive for
XDR-TB.
Patients were diagnosed with XD-RTB retrospectively with the 2006
definition of XDR-TB7.
Culture conversion is defined by having at least two consecutive
negative sputum cultures, at least 1 month apart, and culture positivity
at treatment initiation.
§Time to culture conversion is duration from treatment start date to
date of first negative culture.
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Although XDR-TB in South Africa was initially
thought to be almost exclusively associated with HIV
coinfection (Gandhi et al. 2006), this study shows that
HIV-uninfected HCWs are also at risk of acquiring XDR-
TB. Therefore, MDR- ⁄XDR-TB should be considered in
any HCW suspected of TB, irrespective of HIV status,
and all HCW should be screened with the newer rapid
first- and second-line drug susceptibility tests if they are
found to be smear or culture positive (Pai et al. 2006). All
HCWs in South Africa should also be encouraged to be
tested for HIV, and if HIV-infected, they should receive
appropriate treatment for TB and HIV ⁄AIDS. Upon
recovery, they should also be relocated to work in areas
with lowest risk of TB and in health settings where
appropriate WHO-recommended infection control mea-
sures are being implemented.
The obvious limitations of our study, given its retro-
spective design and ascertainment bias, are the inability to
calculate prevalence estimates, or to precisely delineate
whether the XDR-TB in HCWs was acquired nosocomially
or from the community. The physical, social and economic
consequences of HCWs acquiring XDR-TB can be very
severe and affect their daily lives.
Thus, it becomes important for the South African
government to take immediate measures to provide the
resources required to enable all hospitals and clinics
providing TB care to follow and to implement the
recommended WHO infection control procedures (WHO
Report, 2009). This will go a long way in protecting HCWs
and other inpatients from acquiring MDR- ⁄XDR-TB from
those patients and HCWs who have active disease.
Furthermore, it is important that all health facility
laboratories be equipped with the newer rapid diagnostic
testing platforms now available, so that all patients and
HCWs suspected of having TB need can be identified early,
and appropriately isolated, to minimize the risk of
transmission within hospitals and in the community.
Conclusions
In the Western and Eastern Cape provinces of South Africa
XDR-TB is diagnosed rather late, does not appear to be
related to HIV status and carries a high mortality. This
underscores the need for the government to implement
current WHO policy on TB infection control in all health
care facilities in South Africa. There is also the need for
making available rapid molecular biological DST for all
HCWs and inpatients to rapidly detect, isolate, and treat
all patients with MDR- ⁄XDR-TB. Now that we have
shown that HCWs succumb to XDR-TB, further studies to
establish the source and mode of infection in HCWs, and
the risk to their patients and families, are urgently required.
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